Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
21.09
+0.43 (2.06%)
Sep 8, 2026, 3:14 PM EDT - Market open
Privia Health Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,358 | 2,123 | 1,736 | 1,658 | 1,357 | 966.22 | |
Revenue Growth | 24.10% | 22.26% | 4.75% | 22.19% | 40.41% | 18.25% |
Cost of Revenue | 2,122 | 1,913 | 1,560 | 1,496 | 1,222 | 902.56 |
Gross Profit | 236.52 | 209.43 | 176.85 | 161.5 | 134.78 | 63.66 |
Selling, General & Admin | 179.59 | 165.29 | 152.6 | 134.32 | 149.33 | 278.63 |
Operating Expenses | 191.65 | 175.2 | 159.87 | 140.85 | 153.9 | 281.1 |
Operating Income | 44.88 | 34.24 | 16.98 | 20.65 | -19.12 | -217.44 |
Interest Expense | - | - | - | - | - | -1.07 |
Interest & Investment Income | 7.92 | 9.7 | 10.89 | 8.37 | 0.54 | - |
Pretax Income | 56.11 | 43.94 | 27.87 | 29.02 | -18.58 | -218.51 |
Income Tax Expense | 22.27 | 14.21 | 10.83 | 7.99 | -6.52 | -27.86 |
Earnings From Continuing Operations | 33.84 | 29.73 | 17.04 | 21.03 | -12.06 | -190.65 |
Minority Interest in Earnings | -5.71 | -6.81 | -2.66 | 2.05 | 3.48 | 2.42 |
Net Income | 28.12 | 22.92 | 14.39 | 23.08 | -8.59 | -188.23 |
Net Income to Common | 28.12 | 22.92 | 14.39 | 23.08 | -8.59 | -188.23 |
Net Income Growth | 89.50% | 59.33% | -37.67% | - | - | - |
Shares Outstanding (Basic) | 124 | 122 | 119 | 117 | 111 | 103 |
Shares Outstanding (Diluted) | 130 | 129 | 126 | 125 | 111 | 103 |
Shares Change | 2.73% | 2.61% | 0.74% | 12.64% | 7.52% | 7.30% |
EPS (Basic) | 0.23 | 0.19 | 0.12 | 0.20 | -0.08 | -1.83 |
EPS (Diluted) | 0.22 | 0.18 | 0.11 | 0.19 | -0.08 | -1.83 |
EPS Growth | 99.55% | 63.63% | -42.10% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 131.13 | 163.4 | 109.28 | 80.79 | 47.2 | 54.51 |
Free Cash Flow Per Share | 1.00 | 1.27 | 0.87 | 0.65 | 0.43 | 0.53 |
Gross Margin | 10.03% | 9.87% | 10.18% | 9.74% | 9.93% | 6.59% |
Operating Margin | 1.90% | 1.61% | 0.98% | 1.25% | -1.41% | -22.50% |
Profit Margin | 1.19% | 1.08% | 0.83% | 1.39% | -0.63% | -19.48% |
Free Cash Flow Margin | 5.56% | 7.70% | 6.29% | 4.87% | 3.48% | 5.64% |
EBITDA | 56.94 | 44.14 | 24.25 | 27.18 | -14.55 | -214.97 |
EBITDA Margin | 2.42% | 2.08% | 1.40% | 1.64% | -1.07% | -22.25% |
D&A For EBITDA | 12.06 | 9.91 | 7.27 | 6.53 | 4.57 | 2.46 |
EBIT | 44.88 | 34.24 | 16.98 | 20.65 | -19.12 | -217.44 |
EBIT Margin | 1.90% | 1.61% | 0.98% | 1.25% | -1.41% | -22.50% |
Effective Tax Rate | 39.69% | 32.35% | 38.84% | 27.54% | - | - |